555 related articles for article (PubMed ID: 33613500)
1. Eradication of
Piscione M; Mazzone M; Di Marcantonio MC; Muraro R; Mincione G
Front Microbiol; 2021; 12():630852. PubMed ID: 33613500
[TBL] [Abstract][Full Text] [Related]
2. Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa's cascade underlie its therapeutic effects.
Liu Q; Tang J; Chen S; Hu S; Shen C; Xiang J; Chen N; Wang J; Ma X; Zhang Y; Zeng J
Pharmacol Res; 2022 Oct; 184():106440. PubMed ID: 36108874
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the Correa's cascade steps: A long-term endoscopic surveillance among non-ulcer dyspepsia and gastric ulcer after H. pylori eradication.
Cheng HC; Yang YJ; Yang HB; Tsai YC; Chang WL; Wu CT; Kuo HY; Yu YT; Yang EH; Cheng WC; Chen WY; Sheu BS
J Formos Med Assoc; 2023 May; 122(5):400-410. PubMed ID: 36463082
[TBL] [Abstract][Full Text] [Related]
5. Risk of gastric cancer development after eradication of Helicobacter pylori.
Cheung KS; Leung WK
World J Gastrointest Oncol; 2018 May; 10(5):115-123. PubMed ID: 29770171
[No Abstract] [Full Text] [Related]
6. Pathogenesis and potential reversibility of intestinal metaplasia - a milestone in gastric carcinogenesis.
Drnovsek J; Homan M; Zidar N; Smid LM
Radiol Oncol; 2024 Apr; ():. PubMed ID: 38643513
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].
Muller LB; Fagundes RB; Moraes CC; Rampazzo A
Arq Gastroenterol; 2007; 44(2):93-8. PubMed ID: 17962851
[TBL] [Abstract][Full Text] [Related]
8. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry.
Kuligowski J; Sanjuan-Herráez D; Vázquez-Sánchez MA; Brunet-Vega A; Pericay C; Ramírez-Lázaro MJ; Lario S; Gombau L; Junquera F; Calvet X; Quintás G
J Proteome Res; 2016 Aug; 15(8):2729-38. PubMed ID: 27384260
[TBL] [Abstract][Full Text] [Related]
10. From Sidney to OLGA: an overview of atrophic gastritis.
Crafa P; Russo M; Miraglia C; Barchi A; Moccia F; Nouvenne A; Leandro G; Meschi T; De' Angelis GL; Di Mario F
Acta Biomed; 2018 Dec; 89(8-S):93-99. PubMed ID: 30561425
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori in gastric carcinogenesis.
Ahn HJ; Lee DS
World J Gastrointest Oncol; 2015 Dec; 7(12):455-65. PubMed ID: 26690981
[TBL] [Abstract][Full Text] [Related]
12. GATA-3 augmentation down-regulates Connexin43 in Helicobacter pylori associated gastric carcinogenesis.
Liu X; Cao K; Xu C; Hu T; Zhou L; Cao D; Xiao J; Luo L; Guo Y; Qi Y
Cancer Biol Ther; 2015; 16(6):987-96. PubMed ID: 25901741
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
14.
Liatsos C; Papaefthymiou A; Kyriakos N; Galanopoulos M; Doulberis M; Giakoumis M; Petridou E; Mavrogiannis C; Rokkas T; Kountouras J
World J Gastrointest Oncol; 2022 May; 14(5):959-972. PubMed ID: 35646287
[No Abstract] [Full Text] [Related]
15. Review article: exploring the link between Helicobacter pylori and gastric cancer.
Kuipers EJ
Aliment Pharmacol Ther; 1999 Mar; 13 Suppl 1():3-11. PubMed ID: 10209681
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis.
Xia HH; Talley NJ
Am J Gastroenterol; 2001 Jan; 96(1):16-26. PubMed ID: 11197247
[TBL] [Abstract][Full Text] [Related]
17. Role of Helicobacter pylori cagA(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia.
Peek RM; Vaezi MF; Falk GW; Goldblum JR; Perez-Perez GI; Richter JE; Blaser MJ
Int J Cancer; 1999 Aug; 82(4):520-4. PubMed ID: 10404065
[TBL] [Abstract][Full Text] [Related]
18. [The effect of Helicobacter pylori eradication on chronic gastritis].
Kodama M; Murakami K; Okimoto T; Fujioka T
Nihon Rinsho; 2013 Aug; 71(8):1442-8. PubMed ID: 23967677
[TBL] [Abstract][Full Text] [Related]
19. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.
Kudo M; Gutierrez O; El-Zimaity HM; Cardona H; Nurgalieva ZZ; Wu J; Graham DY
J Clin Pathol; 2005 Mar; 58(3):259-62. PubMed ID: 15735156
[TBL] [Abstract][Full Text] [Related]
20. Association of adenocarcinomas of the distal esophagus, "gastroesophageal junction," and "gastric cardia" with gastric pathology.
Wijetunge S; Ma Y; DeMeester S; Hagen J; DeMeester T; Chandrasoma P
Am J Surg Pathol; 2010 Oct; 34(10):1521-7. PubMed ID: 20871225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
